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ABSTRAK 
 
Pengenalan: Sindrom nefrotik idiopatik adalah jenis sindrom nefrotik yang paling 
lazim dikalangan kanak-kanak. Sebahagian besar pesakit akan pulih sepenuhnya. 
Walaubagaimanapun, sebahagian kecil akan mendapat masalah buah pinggang yang 
kronik. Kami menyiasat median jangkahayat buah pinggang dan faktor-faktor yang 
menyumbang kearah terjadinya masalah buah pinggang kronik dikalangan kanak-kanak 
ini.  
Kaedah: Kaedah semakan rekod secara retrospektif digunakan untuk mendapatkan 
maklumat berkenaan ciri-ciri klinikal, biokemikal dan histologi bagi kanak-kanak yang 
menghidapi  sindrom nefrotik idiopatik yang berusia 12 bulan sehingga 18 tahun ketika 
didiagnos, semenjak tahun 2001 sehingga 2016 di Hospital Universiti Sains Malaysia. 
Tempoh median jangkahayat buah pinggang sehingga terjadinya masalah buah 
pinggang kronik tahap III atau lebih ditentukan dengan menggunakan keluk analisa 
Kaplan-Meier. Cox regresi berbilang digunakan untuk mengenalpasti faktor terjadinya 
masalah buah pinggang kronik. 
Keputusan: Sejumlah 112 subjek (lelaki = 71, perempuan = 41) dianalisa dan majority 
adalah sensitif kepada steroid. Sepuluh peratus mendapat masalah buah pinggang kronik 
Tempoh jangkahayat median buah pinggang bagi jenis sindrom nefrotik kerintangan 
steroid adalah 13 tahun. Fokal segmental glomerulosclerosis adalah jenis paling banyak 
dikalangan jenis kerintangan steroid. Faktor- faktor yang menyumbang kearah kejadian 
masalah buah pinggang kronik adalah jenis kerintangan steroid (HR: 23.8, 95%CI 2.8-
200.9) dan darah tinggi pada permulaan (HR: 8.1, 95% CI 1.2-55.7). 
vii 
 
Kesimpulan: Tempoh median jangkahayat buah pinggang adalah bersamaan dengan 
analisa yang lain. Jenis kerintangan steroid dan darah tinggi pada permulaan adalah 
faktor-faktor utama terjadinya masalah buah pinggang kronik dikalangan subjek kami. 
 
Kata kunci: sindrom nefrotik idiopatik; kanak-kanak; masalah buah pinggan kronik; 
tempoh jangkahayat median buah pinggang; sindrom nefrotik kerintangan steroid 
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ABSTRACT 
 
Introduction: Idiopathic nephrotic syndrome (INS) is the commonest type of nephrotic 
syndrome in children and majority has favourable outcomes. A small proportion of INS 
would progress to chronic kidney disease (CKD). We investigated the timing and 
predictive factors associated with progression of CKD in this children. 
Methods: A retrospective record review was used to investigate the demographic 
variables, biochemical and histological changes in children with INS aged 12 months to 
18 years old from 2001-2016 in Hospital Universiti Sains Malaysia (Hospital USM). 
The median renal survival time to progress to CKD III or higher was determined using 
survival curve analysis. Multiple cox regression was used to identify predictive factors 
related to outcomes to CKD. 
Results: The total of subjects were 112 enrolled (male =71, female= 41) and majority 
was steroid sensitive type. Ten percents of INS progressed to CKD III or higher. The 
median renal survival time in steroid-resistance nephrotic syndromes (SRNS) was 13 
years. Focal segmental glomerulosclerosis (FSGS) was predominant in SRNS type. The 
predictors to progression to CKD were steroid-resistance type (adjusted HR: 23.8, 95% 
CI 2.8- 200.9) and the presence of hypertension at presentation (adjusted HR: 8.1, 95% 
CI 1.2- 55.7).     
Conclusion:  The median renal survival time was comparable to other studies but 
SRNS type and the presence of hypertension at presentation were the main predictors to 
develop CKD in our population.  
 
Key words: idiopathic nephrotic syndrome; children; chronic kidney disease; median 
survival time; steroid-resistance nephrotic syndrome 
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1. INTRODUCTION 
Idiopathic Nephrotic syndrome (INS) has been recognized as one of the most 
frequent glomerular disease in childhood with the worldwide incidence of 2-7/100 000 
children below 16 years old, and the prevalence of 16/100 000
(1)
. Most children with 
INS had favourable outcomes as only small percentage progress to chronic kidney 
disease (CKD). Eighty to ninety percent of children with INS are steroid sensitive 
whereas the remaining 10-20% is steroid-resistance. Fifty to sixty percent of steroid 
resistance nephrotic syndrome (SRNS) progress to CKD
(2)
 with median renal survival 
time 14 years, as compared to 28 years in steroid sensitive type
(3)
. The prevalence of 
CKD was approximately 3-10% 
(3-5)
 in other studies.  
Apart from resistance to steroid therapy, there are other clinical, biochemical and 
histological changes that is associated with progression to CKD. In two separates cohort 
done in Taiwan
(4)
 and Brazil
(3)
, older age is a significant risk towards progression of 
CKD  especially after the age 10 years old
(2)
.  Presence of systemic hypertension and 
hypertensive encephalopathy
(4)
, acute kidney injury (AKI)
(6)
 and microscopic 
haematuria 
(3)
 were also a poor predictive factor in other studies. The histopathological 
findings of focal segmental glomeruloscerosis (FSGS) carries a poor prognostic as up to 
64% will progress to ESRD
(5)
. 
Now researchers are looking at the genetic basis of INS to determine the renal 
outcomes. Genetic study were not available to all in our country, hence not a reliable 
method to determine the outcome of children with INS. Regional data were also 
insufficient. Previous study in Malaysia were looking at the histological findings of 
patient with renal disease
(7)
 specifically adults in Kelantan
(8)
 and children in Johor
(9)
. 
However none of them looking at the overall prevalence, long term outcome, and its 
correlation with CKD. The study was aim to provide the local data of children with INS 
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in Hospital Universiti Sains Malaysia (Hospital USM). We also would like to determine 
the median renal survival time and perhaps would be able to identify early those at the 
highest risk of progression to CKD, thus an early intervention could be done.  
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Dissertation Research Proposal 
TITLE: Renal Survival and Outcome of children and adolescent with  idiopathic 
nephrotic syndrome in Hospital Universiti Sains Malaysia 
 
1. INTRODUCTION 
 
1.1 Background and literature review 
 
Nephrotic syndrome (NS) has been recognized as one of the most frequent 
glomerular disease in childhood with the worldwide incidence of 2-7/100 000 children 
below 16 years old, and the prevalence of 16/100 000 (Skrzypczyk, Panzyk-
Tomaszewska et al, 2014). They are at risk of life threatening complications such as 
peritonitis, venous thrombosis and hypovolemic shock.  
The overall renal survival in Taiwan was 97% at 5 years, and 95% at 10 years. 
(Chang, Tsai et al, 2012) which is comparable to another study done by Mendonca et al 
in Brazil. She predicted that 6% may progress to CKD by 5 years, and 8% by 10 years.  
The long term outcome of nephrotic syndrome is poorer in steroid resistant group 
compared to steroid sensitive group with median survival of 14 years in former groups, 
and 28 years in later group. 
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Risk factor towards progression to CKD among patient with NS  
 
1.1.1. Age  
Children who have NS at earlier age (beyond 1 year old) may have better outcome 
and lesser chance to developed CKD. In 2 separates cohort done in Taiwan and Brazil, 
older age is a significant risk towards progression of CKD (HR 1.15; 95% CI 1.12-
1.21)(Chang, Tsai et al. 2012), (HR 1.25; 95% CI 1.15- 1.37) (Mendonça, Oliveira et al. 
2015) especially after the age 10 years old (Mekahli, Liutkus et al, 2009).  This could be 
attributed by the higher prevalence of minimal change disease (MCD) in younger 
children as compared to higher incidence of focal segmental glomeruslosclerosis 
(FSGS) in older child (Tavares, de Oliviera, 2013).  
 
1.1.2. Gender  
Male gender is more common affected by INS by 1.7- 1.9 but this does not predict 
the outcome of disease (Chang, Tsai et al, 2012), (Mendonca, Oliviera et al, 2015). 
 
1.1.3. Hypertension 
Presence of systemic hypertension and hypertensive encephalopathy among 
patient with NS increase the risk towards progression to CKD (Mendonca. Oliviera et 
al, 2015), (Chang, Tsai et al, 2012), (Fomina, Pavlenko et al, 2010).  Hypertension in 
nephrotic syndrome occurs due to sodium and water retention secondary to activation of 
renin- angiotensin- aldosterone- system (RAAS) or intrinsic renal defect of sodium 
excretion (Ray, Rondon- Berrios et al, 2015).  
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1.1.4. Haematuria 
Initial haematuria as a predictor towards to CKD in NS is not consistent. 
Mendonca et al  found out that the presence of hematuria at presentation significantly 
increase the risk to develop CKD (HR 1.25; 95 % CI 2.5- 11.4) (Mendonca. Oliviera et 
al, 2015), while others was unable to find its significance (Chang, Tsai et al, 2012), 
(Mekahli, Liutkus et al, 2009), (Fomina, Pavlenko et al, 2010).  
 
1.1.5. Acute kidney injury (AKI) 
Initial AKI does significantly increase the risk of progression to CKD (Mekahli, 
Liutkus et al, 2009), (Fomina, Pavlenko et al, 2010), (Mendonca. Oliviera et al, 2015). 
However in other study done in Taiwan, the findings are contradictory as most causes of 
AKI are reversible  (Chang, Tsai et al, 2012), such as hypovolemia, sepsis and 
thrombosis. 
 
1.1.6. Focal segmental glomerulosclerosis (FSGS)  
The histopathological findings of FSGS was significantly increased the risk for CKD 
(HR 6.12; 95% CI 2.50-14.9; p < 0.001) (Mendonca, Oliviera et al, 2015), as early as 3-
5 years (Chang, Tsai et al. 2012), and later 35-64% will progress to ESRD by 10 year 
(Tavares, de Oliviera et al, 2013).  The main pathogenesis is progressive sclerosis that 
occurs in glomeruli. These changes triggers an overexpression of vasoactive factors and 
cytokines, that will leads to further glomerular scarring and damages.  Upon comparing 
children with SRNS, 58% of those with FSGS as opposed to only 4.9% of those with 
Minimal change disease (MCD) progress to ESRD.  Persistent proteinuria is a poor 
prognostic factor among adults with FSGS (HR 11.45; 95% CI 3.11- 42.1) (Tang, Xu et 
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al, 2013), and worst among children (HR 23.2; 95% CI 5.43- 100.3) (Mendonca, 
Oliviera et al, 2015).  
 
1.1.7. Steroid-resistant nephrotic syndrome (SRNS) 
About half of the patient with SRNS is at risk of end-stage renal disease in 5 years if 
they did not achieve remission (KDIGO, 2012).  with the risk of progression to end-
stage renal disease (ESRD) is reaching up to 50% (Mekahli, Liutkus et al, 2009).  The 
survival rate of SRNS at 5 years is 75%, at 10 years is 58% and at 15 years is 53%. 
(Mekahli, Liutkus et al, 2009). 
 
1.2 Problem statement 
 
Children and adolescence are commonly being diagnosed in our clinical practice 
with NS. There are many studies done looking at the long term outcome of NS but data 
in Malaysia, especially Kelantan is limited. Previous studies in Malaysia were looking 
at the histological findings of patient with renal disease (Prathap, Looi et al, 1983) 
specifically adults in Kelantan (Zainal, Riduan et al, 1995) and children in Johor (Khoo, 
Pee et al, 2004). However none of them looking at the overall prevalence, long term 
outcome, and its correlation with CKD. Recently in 2005 the National Kidney 
Foundation (NKF) had developed Malaysia Renal Registry Biopsy (MRRB) to aid in 
data collection of patient with renal disease in Malaysia. However it has limited data 
among children with NS. To date this will be the first retrospective record review 
looking at the demographic characteristics, clinical features, specific laboratory 
investigation and the outcomes of children and adolescence diagnosed with NS in 
Hospital USM.  
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1.2. Justification of the study  
1.2.1.  The study aim to provide the local data of children with nephrotic 
syndrome (NS) in HUSM. 
1.2.2. To determine the renal survival for children and adolescence with NS in 
Hospital USM. 
2. OBJECTIVE  
 
2.1 General objective: 
To study the renal outcomes and risk factors associated with shorter renal survival time 
and among children and adolescence with nephrotic syndrome in Hospital USM 
 
2.2 Specific objectives 
2.2.1 To estimate the renal survival time of children and adolescents with NS  
2.2.2 To determine the associated risk factors (clinical and laboratory features) that 
may contribute to renal survival 
2.2.3 To study the renal outcomes of children and adolescents with NS  
 
2.3 Research questions 
2.3.1 What are the baseline characteristics, clinical presentation and treatment 
response among children and adolescence with nephrotic syndrome in Hospital 
USM? 
2.3.2 What is the renal survival time among children and adolescents with nephrotic 
syndrome in Hospital USM? 
2.3.3 What are the risk factors of the renal survival time among children and 
adolescents with nephrotic syndrome in Hospital USM? 
14 
 
2.4 Research hypothesis  
2.4.1 The renal survival time is comparable to other study  
2.4.2 Presence of studied risk factors that will influence  the renal survival time 
 
2.5  Conceptual frameworks 
 
                 
 
 
 
 
 
 
 
3. METHODOLOGY 
 
3.1 Study design: 
 The study is as retrospective record review study.  
  
nephrotic 
syndrome 
baseline 
characteristics  
clincal features  
laboratory 
investigation 
histological 
changes 
Chronic kidney disease 
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3.2 Study period:  
This study will be conducted from October 2016- June 2017 
 
3.3 Study location: 
This study will done at paediatric nephrology clinic Hospital USM, Kubang Kerian 
 
3.4 Reference population: 
The reference population are children and adolescence patients diagnosed with NS in 
Malaysia 
 
3.5 Source population: 
The source population are children and adolescents patients diagnosed with NS in 
Kelantan 
 
3.6 Sampling frame: 
The sampling frames are children and adolescence patients diagnosed with NS in 
Hospital University Sains Malaysia 
 
 
3.7 Study sample  
The study samples are children and adolescence patients diagnosed with NS in Hospital 
University Sains Malaysia who fulfilled inclusion and exclusion criteria. 
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3.8 Study population 
The study samples are children and adolescents patients diagnosed with NS in Hospital 
University Sains Malaysia who fulfilled inclusion and exclusion criteria, and consented 
to participate in study.  
 
 
 
3.9 Inclusion and exclusion criteria 
3.9.1 Inclusion criteria: 
3.9.1.1 All children diagnosed with NS in paediatric clinic HUSM from 2000- 2015 
3.9.1.2 Age 1 year to 18 years old 
 
3.9.2 Exclusion criteria 
3.9.2.1 Children with infantile & secondary nephrotic syndrome.  
3.9.2.2 Those with missing or untraceable record  
 
3.10 Sample size determination 
The sample size is calculated based on associated risk factor towards renal survival 
time, using power sample (PS) software: 
α = 0.05; power = 0.8, m1 = 26 years (3) 
A= 10 years; F = 5 years 
3.10.1 Factor: steroid resistant nephrotic syndrome (SR NS) 
R = 36.3; m = 2.1 (3) 
N = 63 experimental + 132 control + 39 loss = 234 
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3.10.2 Factor: hematuria 
R = 5.3; m1 = 2.4 (3) 
N = 49 experimental + 118 control + 33 loss = 200 
 
3.10.3 Factor: FSGS 
R = 6.12; m = 1.6 (3) 
N = 54 experimental + 86 control + 28 loss = 188 
 
3.11 Sampling methods 
No sampling method applied for the study. All children who fulfilled the inclusion and 
exclusion will be recruited as the calculated sample size required is more than the 
available sample size. 
 
3.12 Research tool 
Patient’s case study record consisting of demographic data, diagnostic criteria of NS at 
the time of presentation, other clinical manifestations at the time of diagnosis, 
laboratory investigations at the time of diagnosis, renal biopsy details, medications 
given with their total duration as well as other management  modalities such as dialysis.  
 
3.13 Data collection  
Patient with NS will be identified during sampling frame from admission book in 6s 
from and clinic referral form 2000-2015. A list of patients will be printed and sent to 
record office for folder tracing. Patient’s record will be reviewed and only those who 
fulfilled inclusion and exclusion criteria will be included in the study. 
All relevant data were obtained, included  
18 
 
 
3.13.1 Clinical & laboratory features at presentation, including the age, gender, 
race, presence of hypertension, presence of macroscopic or microscopic 
hematuria, and renal impairment 
3.13.2 Current age, weight, height 
3.13.3 Histological finding (if performed) 
3.13.4 Steroid response e.g steroid sensitive and steroid resistant 
 
3.14 Definition of operational terms 
 
3.14.1 Nephrotic syndrome: is a clinical syndrome of oedema, proteinuria 
defined as urine protein: creatinine ratio (uPCR) ≥ 2000mg/g or 
200mg/mmol or 300mg/dl or urine protein 3+ on dipstick, 
hypoalbuminemia define as serum albumin ≤ 2.5g/dL or ≤ 25g/L (10).   
 
3.14.2 Steroid resistant NS: failure to achieve remission after 8 weeks of 
prednisolone 2mg/kg/day or 4 weeks of prednisolone 60mg/m
2
/d  
followed by 1.5mg/kg/d or 40mg/m
2  
alternate dose for 4 weeks (10).  
 
3.14.3 Steroid dependent NS: > 2 consecutive relapse occurring during 
corticosteroid therapy or within 14 days of ceasing of therapy (10) 
 
3.14.4 Relapse: uPCR ≥ 200mg/g or ≥ 200mg/mmol or ≥ 3+ urine protein on 
dipstick for 3 consecutive days (10) 
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3.14.5 Remission: uPCR < 200mg/g or < 20mg/mmol or < 1+ on dipstick for 3 
consecutive days (10). 
 
3.14.6 Frequent relapse NS: 2 or more relapse within 6 months of initial 
response; or  4 or more relapse in any 12-months period (10) 
 
3.14.7 Hypertension: BP > 95th centile for age, weight & height for more than 
3 consecutive reading. (11) 
 
3.14.8 Pre- hypertension: BP 90th-95th  centile for age, weight & height (11) 
 
3.14.9 Macroscopic hematuria: presence of gross red blood cells (RBC) in 
urine (12) 
 
3.14.10Microscopic hematuria: presence of more than 2  rbc per high power 
field (hpf) (12) 
 
3.14.11Chronic kidney disease: abnormalities of kidney structure or function 
for more than 3 months with implication of health. Criteria of CKD: (13) 
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**Estimated glomerular filtration rate (eGFR) < 60ml/mt is considered significant as at 
it is associated with complications such as altered drug excretion, impaired exocrine and 
metabolic function of kidney, as well as higher risk of cardiovascular disease & death 
(13)   
 
eGFR will be calculated  based on Schwartz formula: (13) 
                                  
 
3.15 Study Flow chart 
 
 
  
Patients with NS were identified using database at record office 
and folder tracing 
Fullfilled inclusion and exlcusion criteria  
Data collection,entry, analysis and interpretation  
Report writing and preparation for presentation 
Submission for dissertation  
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3.16 Intended statistical analysis 
The data will be processed and analyzed using IBM SPSS Statistics version 20. 
Numerical data will be presented as mean and standard deviation (Mean, SD) 0r median 
and interquartile range (Median 25
th
, 75
th
) depending on distribution. The categorical 
data is expressed as number and percentage. 
 The endpoint is the occurrence of chronic kidney disease (CKD). Renal survival 
was measured from the date of diagnosis to the date of last estimated eGFR meeting 
criteria of CKD. Median survival time will be determined using Kaplan-Meir 
regression. Potential variables will be examined against the endpoint by univariate 
analysis using log rank test, and multivariate analysis with Cox proportional hazards. P 
value of less than 0.05 will be considered significant.   
 
3.17 4.Ethical issue  
This study will be conducted in concordance with Declaration of Helsinki and 
follows Malaysian Good Clinical Practice (GCP) Guidelines. Ethical clearance will be 
obtained from Research Ethics Committee. Personal information will be safeguarded to 
ensure confidentiality. The risk of to the safety or health of participants of the study is 
very minimal. 
All forms are anonymous using code number and will be entered into SPSS 
software. Only research team members can access the data. Data will be presented as 
grouped data and will not identify the responders individually. A separate list of names, 
registration number with code number will be kept by the researcher in a locked cabinet.  
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EXPECTED RESULTS 
 
4.1 Descriptive statistics 
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Fig. 2 Renal survival according to age at diagnosis 
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Fig. 3 Renal survival according to steroid response 
Fig. 4 Renal survival according to histological changes 
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4.2 Inferential statistics:  
 
median survival time 
     
estimate  
std 
error 
mean   median 
95% CI     95% CI 
lower 
bound 
upper 
bound estimate  
std 
error 
lower 
bound 
upper 
bound 
                
 
 
log rank test for categorical variables 
 
    age <10 years old and > 
10 years old 
     chi-square df sig.  
log rank (Mantel-cox)       
    
 
 
 
hematuria (absence or presence) 
  chi-square df sig.  
log rank (Mantel-cox)       
    
 
  
